Launch
Website- Bupa Platinum consultant
-
Fee assured
-
Verified account
- Open Referral network
Specialises in
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Dallas is a Consultant Clinical Oncologist for NHS patients at the Royal Berkshire Hospital in Reading and Wexham Park Hospital in Slough and has been a partner in the Berkshire Oncology Partnership since 2012.
Dr Dallas graduated from the University of Birmingham Medical School in 1998 and became a member of the Royal College of Physicians in 2001. She completed her specialist oncology training in Oxford becoming a Fellow of the Royal College of Radiologists in 2007. She was appointed as a Consultant Clinical Oncologist at the Berkshire Cancer Centre, Royal Berkshire Hospital in Reading in 2011.
Dr Dallas specialises in the treatment of prostate, bladder, kidney and testicular cancers, head and neck and thyroid cancers. She has a particular interest in technical radiotherapy techniques including IMRT, dynamic arc IMRT and IGRT.
She is the principle investigator for a number of phase 3 clinical trials in urological and head and neck cancers.
At the Berkshire Cancer Centre she is the Clinical Governance and Audit Lead as well as an educational and clinical supervisor to specialist oncology trainees.
Areas of interest
Urology; prostate cancer; bladder cancer;kidney cancer; renal cancer; testicular cancer; germ cell tumours; head & neck cancer; oropharyngeal cancer, tonsil cancer; tongue cancer; nasopharyngeal cancer; salivary gland tumours; thyroid cancer; radiotherapy; IMRT; IGRT; Stereotactic radiotherapy; SABR; SBRT; MR Linac, Hormone therapy; chemotherapy; immunotherapy; biological therapies; therapeutic radioisotopes
Medical secretaries
- Trudy Wallum
- Genesiscare Windsor 69 Alma Road Windsor SL4 3HD
- 01753 418568
- practicemanager@berkshire-oncology.org.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
GenesisCare, Windsor (1-5)
-
X6581
Clinical supervision of the delivery of a single fraction of radiotherapy - (5-50)
GenesisCare, Windsor (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
GenesisCare, Windsor (1-5)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)
GenesisCare, Windsor (5-50)
-
X6774
Preparation for intermediate radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)
GenesisCare, Windsor (5-50)
-
X0001
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (5-50)
-
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)
GenesisCare, Windsor (5-50)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
GenesisCare, Windsor (1-5)
-
S5300
Introduction of substance into skin (including hormone pellet) - (1-5)
GenesisCare, Windsor (1-5)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (1-5)